STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma

BACKGROUND: Pancreatic ductal adenocarcinoma (PDA) is a highly lethal cancer characterized by complex aberrant genomes. A fundamental goal of current studies is to identify those somatic events arising in the variable landscape of PDA genomes that can be exploited for improved clinical outcomes. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Evers, Lisa, Perez-Mancera, Pedro A, Lenkiewicz, Elizabeth, Tang, Nanyun, Aust, Daniela, Knösel, Thomas, Rümmele, Petra, Holley, Tara, Kassner, Michelle, Aziz, Meraj, Ramanathan, Ramesh K, Von Hoff, Daniel D, Yin, Holly, Pilarsky, Christian, Barrett, Michael T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971348/
https://www.ncbi.nlm.nih.gov/pubmed/24484537
http://dx.doi.org/10.1186/gm526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971348/
https://www.ncbi.nlm.nih.gov/pubmed/24484537
http://dx.doi.org/10.1186/gm526

Ejemplares similares